ARCHIVES

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Techniclone Wins Patent For Tumor Necrosis Therapy.

February 25, 2000

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003

Cohen Directs UK’s Markey Cancer Center; Matrisian Named Chairman, DOD Panel.

September 8, 2000

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

NCI, DOE Working Out Details Of Converting Portion Of Idaho Facility to Work On BNCT

July 1, 1988